We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-5.02%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$593M
AUM Growth
-$12M
Cap. Flow
+$24.6M
Cap. Flow %
4.16%
Top 10 Hldgs %
49.61%
Holding
3,046
New
350
Increased
1,337
Reduced
784
Closed
167

Top Buys

Rank Stock Value
1
RPAR icon
RPAR Risk Parity ETF
RPAR
+$5.24M
2
GBDC icon
Golub Capital BDC
GBDC
+$3.49M
3
OCSL icon
Oaktree Specialty Lending
OCSL
+$3.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$2.79M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.48M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.03M
2
NKE icon
Nike
NKE
+$772K
3
VTV icon
Vanguard Morningstar Value ETF
VTV
+$728K
4
KMI icon
Kinder Morgan
KMI
+$708K
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$594K

Sector Composition

Rank Sector Weight
1 Financials 19.66%
2 Technology 11.68%
3 Healthcare 5.39%
4 Consumer Discretionary 4.17%
5 Energy 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMPL icon
1976
Amplitude
AMPL
$1.52B
$2K ﹤0.01%
+106
New +$1.7K
ANF icon
1977
Abercrombie & Fitch
ANF
$5.27B
$2K ﹤0.01%
126
-74
-37% -$1.28K
AORT icon
1978
Artivion
AORT
$1.28B
$2K ﹤0.01%
+109
New +$2.19K
APPF icon
1979
AppFolio
APPF
$7.07B
$2K ﹤0.01%
16
+13
+433% +$1.33K
ARRY icon
1980
Array Technologies
ARRY
$819M
$2K ﹤0.01%
113
-5
-4% -$86
ASIX icon
1981
AdvanSix
ASIX
$439M
$2K ﹤0.01%
75
-5
-6% -$180
ATNI icon
1982
ATN International
ATNI
$494M
$2K ﹤0.01%
61
-11
-15% -$498
ATRA icon
1983
Atara Biotherapeutics
ATRA
$77.6M
$2K ﹤0.01%
20
+10
+100% +$1.12K
AVDX
1984
DELISTED
AvidXchange
AVDX
$2K ﹤0.01%
+274
New +$2.12K
AVIR icon
1985
Atea Pharmaceuticals
AVIR
$402M
$2K ﹤0.01%
289
-24
-8% -$184
AVNT icon
1986
Avient
AVNT
$4.19B
$2K ﹤0.01%
70
+17
+32% +$704
AXGN icon
1987
Axogen
AXGN
$2.59B
$2K ﹤0.01%
167
-29
-15% -$290
AXSM icon
1988
Axsome Therapeutics
AXSM
$11.4B
$2K ﹤0.01%
52
+43
+478% +$2.15K
BARK icon
1989
BARK
BARK
$96.7M
$2K ﹤0.01%
53
+35
+194% +$1.29K
BATRA icon
1990
Atlanta Braves Holdings Series A
BATRA
$3.42B
$2K ﹤0.01%
77
– –
BBIO icon
1991
BridgeBio Pharma
BBIO
$16.6B
$2K ﹤0.01%
169
+111
+191% +$1.15K
BCRX icon
1992
BioCryst Pharmaceuticals
BCRX
$2.51B
$2K ﹤0.01%
140
-78
-36% -$1K
BDC icon
1993
Belden
BDC
$5.28B
$2K ﹤0.01%
28
+19
+211% +$1.21K
BHE icon
1994
Benchmark Electronics
BHE
$2.92B
$2K ﹤0.01%
71
+39
+122% +$996
CMRC
1995
Commerce.com Inc Series 1
CMRC
$175M
$2K ﹤0.01%
+111
New +$1.9K
BLFS icon
1996
BioLife Solutions
BLFS
$1.69B
$2K ﹤0.01%
89
+54
+154% +$1.16K
BLND icon
1997
Blend Labs
BLND
$357M
$2K ﹤0.01%
+1,064
New +$3.02K
BLUE
1998
DELISTED
bluebird bio
BLUE
$2K ﹤0.01%
15
+13
+650% +$1.47K
BMI icon
1999
Badger Meter
BMI
$3.95B
$2K ﹤0.01%
19
+13
+217% +$1.21K
BOX icon
2000
Box
BOX
$4.65B
$2K ﹤0.01%
81
+48
+145% +$1.32K
78 79
80
81 82

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Lindbrook Capital held 3,046 positions worth $593M, down 2% from $605M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Lindbrook Capital deployed $24.6M of net new capital in Q3 2022, opening 350 new positions and adding to 1,337 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1 share worth $406K.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $1.03M trimmed.

  • Lindbrook Capital's largest Q3 2022 buy was Berkshire Hathaway Class A: 1 share worth $406K.
  • Lindbrook Capital added most to RPAR Risk Parity ETF in Q3 2022, an estimated $5.24M increase.
  • Lindbrook Capital's biggest Q3 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $1.03M.
  • Lindbrook Capital fully exited ProShares UltraShort S&P500 in Q3 2022, selling an estimated $219K.
  • Lindbrook Capital's ten largest holdings make up 50% of its $593M portfolio in Q3 2022.
  • Lindbrook Capital opened 350 new positions and closed 167 in Q3 2022.
  • Lindbrook Capital's portfolio value fell 2% quarter-over-quarter to $593M.

Based on Lindbrook Capital's 13F filing for Q3 2022, filed 10 Nov 2022.